Toggle Main Menu Toggle Search

Open Access padlockePrints

Common toxidromes in movement disorder neurology

Lookup NU author(s): Professor Mark BakerORCiD


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


© 2016 The Fellowship of Postgraduate Medicine. Background Physicians can come across patients who are exposed to certain prescription drugs or toxins that can result in adverse effects and complications which have high rates of morbidity and mortality. Objective To summarise the key clinical features and management of the common movement disorder toxidromes relevant to physicians (with an interest in neurology). Methods We searched PUBMED from 1946 to 2016 for papers relating to movement toxidromes and their treatment. The findings from those studies were then summarised and are presented here. Results The key features of 6 of the common movement disorder toxidromes and their treatment are tabulated and highlighted. The management of toxidromes with the highest mortality like neuroleptic malignant syndrome and serotonin syndrome are discussed in detail. Conclusion There are several toxidromes that have the potential to become a serious life-threatening emergency if there is a delay in recognition of key clinical features and instituting the appropriate treatment at the earliest is crucial.

Publication metadata

Author(s): Malek N, Baker MR

Publication type: Article

Publication status: Published

Journal: Postgraduate Medical Journal

Year: 2017

Volume: 93

Issue: 1100

Pages: 326-332

Print publication date: 01/06/2017

Online publication date: 07/10/2016

Acceptance date: 14/09/2016

ISSN (print): 0032-5473

ISSN (electronic): 1469-0756

Publisher: BMJ Publishing Group


DOI: 10.1136/postgradmedj-2016-134254


Altmetrics provided by Altmetric